# Cervical cancer in Cape Verde: reappraisal upon referral to a tertiary cancer centre in Lisbon

Source: https://onco.cc/key-papers/paper-vilares-cervical-cancer-cape-verde-referral-ecancer-2022/  
OnCo record `paper-vilares-cervical-cancer-cape-verde-referral-ecancer-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Fifty-eight women diagnosed with cervical cancer in Cabo Verde were treated in Lisbon from 2013 to 2020 under a health cooperation agreement. About six months passed between diagnosis and treatment, and the stage found in Lisbon matched the original in 15.5% of cases.

## Summary

A retrospective evaluation of women diagnosed with cervical cancer in Cabo Verde who were evacuated for treatment to the Instituto Português de Oncologia de Lisboa Francisco Gentil between 2013 and 2020, reviewing risk factors, tumour characteristics, treatment and outcomes.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: ecancermedicalscience
- Year: 2022
- DOI: 10.3332/ecancer.2022.1471
- Authors: Vilares AT, Ciabattoni R, Cunha TM, Félix A.
- Findings: Squamous cell carcinoma was the most frequent type (91.5%); HPV DNA was present in 25 of 26 samples tested.; Pathology in Cabo Verde and in Portugal agreed in 87.9% of cases, but FIGO stage agreed in 15.5%.; The interval between diagnosis and treatment was around 6 months.; 77.6% received combined chemotherapy and radiotherapy in Lisbon.; The survival rate in the cohort was 89.7% and median overall survival 73.2 months.
- What it means: Women who reach treatment abroad do well, but the wait is long and staging at home is limited; the authors link the disagreement on stage to both.
- Caveats: Only women who were evacuated and treated are included, so the results do not describe all women with cervical cancer in Cabo Verde.; The abstract describes the absence of a national screening programme and of dedicated cancer treatment facilities at the time of the study.

## Sources

- DOI: https://doi.org/10.3332/ecancer.2022.1471
- PubMed: https://pubmed.ncbi.nlm.nih.gov/36819824/

## Connected records

- key papers: [Breast cancer in Cape Verde: clinical and molecular profile and the impact of an international treatment partnership](https://onco.cc/key-papers/paper-borges-breast-cancer-cape-verde-partnership-jcogo-2026/)
- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Instituto Português de Oncologia de Lisboa Francisco Gentil](https://onco.cc/institutions/ipo-lisboa/)

---
JSON: https://onco.cc/api/v1/entities/paper-vilares-cervical-cancer-cape-verde-referral-ecancer-2022.json